Showing results (1561-1570 of 1,654) with videos related to
Sort By:
Pageof 166
Drug Metabolism and Personalized Therapy|August 23, 2020
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluationDmitriy V Ivashchenko, Sofi Z Khoang, Bakhu V Makhmudova, et al.Human Psychopharmacology|October 26, 2018
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markersMichael S Zastrozhin, Aleksandr S Sorokin, Tatyana V Agibalova, et al.Leukemia Research|March 6, 2021
The outcome of Ph-negative acute lymphoblastic leukemia presenting during pregnancy and treated on the Russian prospective multicenter trial RALL-2009Elena N Parovichnikova, Vera V Troitskaya, Olga A Gavrilina, et al.Terapevticheskii Arkhiv|October 26, 2022
[Li-Fraumeni syndrome in adult patients with acute lymphoblastic leukemia]K I Zarubina, E N Parovichnikova, V L Surin, et al.Terapevticheskii Arkhiv|January 21, 2014
[Treatment for acute promyelocytic leukemia during pregnancy]V V Troitskaia, E N Parovichnikova, A N Sokolov, et al.Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 28, 2026
Urinary tract infections in pregnant women from the Russian--Ukrainian military conflict regions: A multicenter study (2022-2025)Aidyn G Salmanov, Anatolii Senchuk, Beraia Dzheneti, et al.Voprosy Onkologii|July 2, 2013
[Biodistribution of the recombinant heat shock protein rhHsp70 in intracranial C6 glioma models in Wistar rats and subcutaneos B16/F10 melanoma in C57BL/6 mice]M A Shevtsov, S V Shatik, Tokarev, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|February 22, 2020
Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases disseminationAnastasiia S Garanina, Victor A Naumenko, Aleksey A Nikitin, et al.Journal of Medicinal Chemistry|October 25, 2016
Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 InteractionAndreas Gollner, Dorothea Rudolph, Heribert Arnhof, et al.Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 28, 2017
[Use of the IntelliVent-ASV mode for maintaining the target EtCO2 range in patients with severe TBI]E P Anan'ev, A A Polupan, I V Matskovskiy, et al.Pageof 166